Michael J. Walters

Part of AbbVie, Inc., SourceCF, Inc. is a company that develops medical equipment and vitamins related to cystic fibrosis. The company is based in Huntsville, AL. The company was founded by Michael J. Walters. SourceCF was acquired by Eurand NV on December 03, 2007 for $9.60 million.

Eurand, Inc. develops pharmaceutical and biopharmaceutical products based on its proprietary drug delivery technologies. The company has had three products approved by the FDA since 2000. The company's most advanced development product, a treatment for exocrine pancreatic insufficiency associated with cystic fibrosis and other diseases, is currently undergoing Phase III clinical trials in the United States. It's technology platforms include: bioavailability enhancement of poorly soluble drugs, customized release, taste masking/fast dissolving formulations and drug conjugation. The company was founded in 1969 and is headquartered in Vandalia, OH.

Eurand NV develops pharmaceutical and biopharmaceutical products using proprietary drug formulation technologies. The company was founded in 1984 and is headquartered in Amsterdam, the Netherlands.